Search Results - charles+lockwood

1 Results Sort By:
Neuronal suppression of FKBP51 expression by fatty acid derivatives to prevent mental disorders
­Advantages: The study highlights FKBP51 as a promising target for the treatment of disorders such as major depression, PTSD, anxiety disorders, and Alzheimer's disease. The research recognizes the influence of single nucleotide polymorphisms (SNPs) in the FKBP5 gene on FKBP51 levels and susceptibility to certain disorders. The researchers...
Published: 9/3/2024   |   Inventor(s): Charles Lockwood, Laura Blair, Ozlem Guzeloglu-Kayisli, Umit Kayisli
Keywords(s): Biotechnology, Medical Pharmaceuticals, Neurodegenerative Diseases, Therapeutics
Category(s): Technology Classifications > Medical > Biotechnology, Technology Classifications > Medical > Neuroscience, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical > Therapeutics